United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2017_register executive 2017-07-26 article Notices D09002ee1c7f12996 D09002ee1c7f12a17 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Patient Engagement Advisory Committee (PEAC). The general function of the committee is to provide advice and recommendations to the Agency on complex issues relating to medical devices, the regulation of devices, and their use by patients. The meeting will be open to the public. This meeting will be the inaugural meeting of a new advisory committee. 82 FR 34681 https://www.govinfo.gov/app/details/FR-2017-07-26/2017-15657 2017-15657 fr26jy17-56 4164-01-P Docket No. FDA-2017-N-0001 https://www.govinfo.gov/app/details/FR-2017-07-26/2017-15657 https://www.govinfo.gov/content/pkg/FR-2017-07-26/html/2017-15657.htm https://www.govinfo.gov/content/pkg/FR-2017-07-26/pdf/2017-15657.pdf 2 p. 34681 34682 82 FR 34681 Patient Engagement Advisory Committee; Notice of Meeting; Federal Register Vol. 82, Issue NOTICE 2017-15657 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 2017-10-11 Docket No. FDA-2017-N-0001 4164-01-P 2017-15657 Notice.

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Patient Engagement Advisory Committee (PEAC). The general function of the committee is to provide advice and recommendations to the Agency on complex issues relating to medical devices, the regulation of devices, and their use by patients. The meeting will be open to the public. This meeting will be the inaugural meeting of a new advisory committee.

The meeting will be held on October 11, 2017, from 1 p.m. to 5 p.m. and October 12, 2017, from 8 a.m. to 5 p.m. Letise Williams, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5441, Silver Spring, MD 20993-0002, 301- 796-8398, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting. Meetings: Patient Engagement Advisory Committee , Annmarie.Williams@fda.hhs.gov http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm http://www.fda.gov/AdvisoryCommittees/default.htm Vol. 82, no. 142 Office of the Federal Register, National Archives and Records Administration 2017-07-26 continuing daily deposited born digital 245 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2017-07-26 P0b002ee195b8cc90 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr26jy17 https://www.govinfo.gov/app/details/FR-2017-07-26 https://www.govinfo.gov/content/pkg/FR-2017-07-26/pdf/FR-2017-07-26.pdf https://www.govinfo.gov/content/pkg/FR-2017-07-26/xml/FR-2017-07-26.xml fdlp 34597 34789 DGPO 2017-07-26 2024-06-01 FR-2017-07-26 machine generated eng FR FR-2017-07-26 82 142